Genedrive PLC Distribution agreement (5536R)
March 09 2021 - 1:00AM
UK Regulatory
TIDMGDR
RNS Number : 5536R
Genedrive PLC
09 March 2021
genedrive plc
("genedrive" or the "Company")
Genedrive enters distribution agreement with Mountain Horse
Solutions
Distribution of genedrive's Military Assays and Instrument in
the United States
genedrive plc (AIM: GDR), the near patient molecular diagnostics
company, announces that it has entered into an agreement for the
distribution of the Company's military pathogen detection assays in
the United States with Mountain Horse Solutions ("Mountain Horse"),
a military contracting specialist to U.S. Federal, State, and Local
Government customers.
genedrive has a unique product with regard to military CBRNE(1)
requirements. The Genedrive(R) BioPlex range of products was
developed to the U.S. Department of Defense's (U.S. DoD) product
specification with the help of U.S. DoD funding. Designed for field
portability and rapid determination of biothreats from pathogens,
the Genedrive BioPlex system was developed over a period of five
years and has been approved to deployment stage.
Contracting with the U.S. Government can be challenging and time
consuming. The Company believes that establishing new, local
representation in the United States with identified contacts in
this highly specialised field will help drive broader product
uptake. Organisations like Mountain Horse are already contracted
with the U.S. Government, which includes existing framework
purchasing agreements, providing an opportunity for more rapid
order placement and replenishment of products without the need for
new contracts to be negotiated.
Bill Allen, President of Mountain Horse Solutions, said: "We are
delighted to be working with genedrive with these exciting pathogen
detection products. The addition of genedrive's assays to our
portfolio of CBRNE mission critical products provides a unique
offering of combat-ready sampling and detection devices."
David Budd, CEO of genedrive plc, said: "The agreement allows
the supply of our BioPlex pathogen detection assays through
Mountain Horse, a military contracting specialist who has a number
of existing framework contracts with target clients such as the
U.S. DoD. We believe that they have both the industry sector
knowledge and existing commercial arrangements to increase the
exposure of our products and gain new customer opportunities within
the various branches and departments of the DoD and U.S.
Government."
1. Chemical Biological Radiological, Nuclear and Explosive
For further details please contact:
genedrive plc +44 (0)161 989 0245
David Budd: CEO / Matthew Fowler:
CFO
Peel Hunt LLP (Nominated Adviser
and Joint Broker) +44 (0)20 7418 8900
James Steel / Oliver Jackson
finnCap (Joint Broker) +44 (0)20 7220 0500
Geoff Nash / Kate Bannatyne / Alice
Lane
Walbrook PR Ltd (Media & Investor +44 (0)20 7933 8780 or genedrive@walbrookpr.com
Relations)
+44 (0)7980 541 893 / +44 (0)7876
Paul McManus / Anna Dunphy 741 001
About genedrive plc ( http://www.genedriveplc.com ) genedrive
plc is a molecular diagnostics company developing and
commercialising a low cost, rapid, versatile, simple to use and
robust point of need molecular diagnostics platform for the
diagnosis of infectious diseases and for use in patient
stratification (genotyping), pathogen detection and other
indications. The Company has assays on market for the detection of
HCV, certain military biological targets, and has tests in
development for tuberculosis (mTB). The Company recently released a
high throughput SARS-CoV-2 assay and has in development a
Genedrive(R) Point of Care version of the assay, both based on
Genedrive(R) chemistry.
About Mountain Horse Solutions
Mountain Horse Solutions supplies rapid response customized
equipment, systems, and training for infectious disease, security,
technology, chemical, biological, radiological, nuclear, and
explosive (CBRNE) hazards. We specially design innovative
solutions, to meet the individual unique threats, needs, and
requirements of the military, and first responders. Our team of
professionals from around the globe has extensive experience with
commercial, DOD, and U.S. Federal Government customers. Mountain
Horse Solutions serves organizations, agencies, and contractors
worldwide. To find out more visit : www.mtnhorse.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGRBIGDXBXGDGBI
(END) Dow Jones Newswires
March 09, 2021 02:00 ET (07:00 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2023 to Apr 2024